MAIA Biotechnology, Inc.
MAIANext catalyst
6-Thio-2'-Deoxyguanosine
Carcinoma, Non-Small-Cell Lung
Get an email about MAIA's next catalysts
Track MAIA Biotechnology (MAIA) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
Plus 2 more upcoming events in our data (earnings, Phase 2 readout).See the timeline
3 upcoming, 0 past
MAIA Earnings Report
Date estimated from past reporting pattern, not yet confirmed by the company | EPS Est: $-0.13 | FQ end Sep/2026 | Call: tbd
6-Thio-2'-Deoxyguanosine Phase 3 Est. Readout
Primary completion for 6-Thio-2'-Deoxyguanosine trial (NCT06908304) in Carcinoma, Non-Small -Cell Lung
Source6-Thio-2'-Deoxyguanosine Phase 2 Est. Readout
Primary completion for 6-Thio-2'-Deoxyguanosine trial (NCT05208944) in Carcinoma, Non-Small-Cell Lung
SourceMarket Overview
Stock performance and key metrics
MAIA Biotechnology, Inc. is a public, immune-oncology company based in Chicago, IL focused on the development of telomere targeting agents for the treatment of telomerase-positive cancer cells.
Website6-Thio-2'-Deoxyguanosine
Carcinoma, Non-Small-Cell Lung
Vinorelbine
Carcinoma, Non-Small -Cell Lung
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
6-Thio-2'-Deoxyguanosine | Phase 3 | Carcinoma, Non-Small-Cell Lung | - | - |
Vinorelbine | Phase 3 | Carcinoma, Non-Small -Cell Lung | - | - |
Frequently asked questions
What is in MAIA Biotechnology, Inc.'s drug pipeline?→
CatalystAlert tracks 2 drug candidates in MAIA Biotechnology, Inc.'s (MAIA) pipeline across Phase 3. Its lead program is 6-Thio-2'-Deoxyguanosine (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is MAIA Biotechnology, Inc.'s next FDA catalyst?→
MAIA Biotechnology, Inc.'s (MAIA) next tracked catalyst is a Phase 3 readout expected Q3 2027. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track MAIA biotech catalysts?→
Add MAIA to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow MAIA Biotechnology, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.